| Melanie S Byram, MD | |
|
930 Hayes Drive, Suite B, Manhattan, KS 66502 | |
| (785) 565-0016 | |
| (785) 565-0003 |
| Full Name | Melanie S Byram |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 930 Hayes Drive, Manhattan, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457355216 | NPI | - | NPPES |
| 101142 | Other | KS | BLUE CROSS BLUE SHIELD |
| 460855 | Other | KS | CHILDRENS MERCY FAMILY HP |
| 100119380B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 22333 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Angels Care Home Health | Wichita, KS | Home health agency |
| Hand In Hand Hospice | Emporia, KS | Hospice |
| Morris County Hospital | Council grove, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Morris County Hospital | 8426096504 | 11 |
News Archive
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.
The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death-and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
› Verified 4 days ago
| Entity Name | Carearc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467413906 PECOS PAC ID: 2961474663 Enrollment ID: O20040812000395 |
News Archive
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.
The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death-and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
› Verified 4 days ago
| Entity Name | K Stat Urgent Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356553481 PECOS PAC ID: 0244392322 Enrollment ID: O20081224000319 |
News Archive
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.
The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death-and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
› Verified 4 days ago
| Entity Name | Morris County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295217305 PECOS PAC ID: 8426096504 Enrollment ID: O20181121000648 |
News Archive
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.
The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death-and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melanie S Byram, MD 930 Hayes Drive, Suite B, Manhattan, KS 66502 Ph: (785) 565-0016 | Melanie S Byram, MD 930 Hayes Drive, Suite B, Manhattan, KS 66502 Ph: (785) 565-0016 |
News Archive
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM therapeutic, the first treatment developed utilizing its iSPERSE inhaled drug platform, will be presented at the European Respiratory Society (ERS) Annual Congress taking place September 1-5, 2012, in Vienna, Austria.
The U.S. Food and Drug Administration today approved Xtandi (enzalutamide) to treat men with late-stage (metastatic) castration-resistant prostate cancer that has spread or recurred, even with medical or surgical therapy to minimize testosterone.
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death-and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
› Verified 4 days ago
Bradley Keith Harrison, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1133 College Ave, Suite A211, Manhattan, KS 66502 Phone: 785-320-5000 Fax: 888-524-2251 | |
Andrew Pope, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4101 Anderson Ave, Manhattan, KS 66503 Phone: 785-587-4101 | |
Jennifer Kathleen Malcolm, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1105 Sunset Ave, Manhattan, KS 66502 Phone: 785-532-6544 Fax: 785-532-3425 | |
Dr. Keith A Wright, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4101 Anderson Ave, Manhattan, KS 66503 Phone: 785-587-4101 Fax: 785-587-9090 | |
Robert David Ecklund, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1105 Sunset Ave, Manhattan, KS 66502 Phone: 785-532-7755 Fax: 785-532-6627 | |
Danielle Justine Thornsberry, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1105 Sunset Ave, Manhattan, KS 66502 Phone: 785-532-6544 Fax: 855-618-0188 | |
Dr. Regan Michele Tilley, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7840 E Us 24 Hwy, Manhattan, KS 66502 Phone: 785-775-1155 Fax: 785-775-1156 |